• Contact quintiles

    Phone:+1 866 267 4479

    Request a Proposal

  • P.R. China

    Quintiles China has been operating for more than a decade with two offices in China’s major cities of Beijing and Shanghai.

  • 在中國,點擊查看此頁面

    Quintiles China has been operating for more than a decade with three offices in China’s major cities of Beijing, Shanghai and Dalian. We provide a range of services from monitoring Phase II-IV clinical trials to marketing and selling drugs in every major therapeutic area.

    Benefits of Working with Quintiles China

    • Rapid access to an enormous patient population with a disease prevalence that increasingly mirrors that of Western nations
    • 24/7 communications on secure networks for data retrieval and real-time posting of updates for tracking study progress or patient recruitment
    • All procedures and data produced adhere to FDA, EMEA and ICH GCP standards 

    Key Services in China

    • Clinical monitoring and site management
    • Central labs
    • Project management
    • Commercialisation services
    • Regulatory services

    Our locations in China:

    Unit 901-919, Office Tower 3 Sun Dong Ann Plaza 138,
    Wang Fu Jing Ave., Dong Cheng Dist. Beijing 100006, P. R. China
    + 86 10 5911 7888
    3F, 5F Building A,
    388 Feng Lin Road,
    Shanghai, 200032, P. R. China
    +86 21 2422 8888
    10-02/04 10F Bldg#1 Hui Xian Yuan
    Dalian High-tech Industrial Zone
    Dalian 116025, P. R. China
    + 86 411 8498 8188

  • China Perspectives

  • Quintiles

    Methods Matter

    As healthcare decision making becomes more complex, stakeholders are demanding real-world evidence tailored to their own individual needs.  Read white paper

  • Quintiles

    Strategies for Success in China Outlined in New Quintiles-sponsored Report by Economist Intelligence Unit

    A new Economist Intelligence Unit report sponsored by Quintiles concludes that “China is a complex market that can yield profits to those companies that jump in with both feet, adapt to the realities of doing business in China, and actively protect their interests in this dynamic business environment.”  Read more